RIPK4 and melanoma: Our previous studies have shown that downregulation of RIPK4 impairs signalling pathways important for the survival and progression of melanoma, such as NFκB [24,31] and Wnt/β-catenin [25], which are also involved in the regulation of ABCG2 protein levels [50,51].